Global Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2024

Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025 – By Offering (Hardware, Software, Services), By Deployment (Cloud, On-Premises), By Technology (Machine Learning, Natural Language Processing, Deep Learning, Other Technologies), By Application (Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine), By End-Users (Manufacturers, Contract Research Organizations, Academic And Government Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Artificial Intelligence (AI) In Biopharmaceuticals Market Definition

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.

The main types of offerings in artificial intelligence (AI) in biopharmaceuticals are hardware, software, and services. Hardware refers to the physical components of a computer system, including devices such as memory, disk drives, controllers, and specialized software like database management systems. It includes various deployments, including cloud and on-premises, and the technologies used are machine learning, natural language processing, and deep learning, as well as applications used in business processes and supply chains, drug discovery, medical imaging and diagnostics, and precision medicine, end users are manufacturers, contract research organizations, and academic and government research institutes.

Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Artificial Intelligence (AI) In Biopharmaceuticals Market Size and growth rate 2025 to 2029: Graph

Artificial Intelligence (AI) In Biopharmaceuticals Market Size 2025 And Growth Rate

The artificial intelligence (AI) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $1.59 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to advancements in computational power, biomedical data explosion, precision medicine paradigm, regulatory support and guidance.

Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Forecast

The artificial intelligence (AI) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $6.67 billion in 2029 at a compound annual growth rate (CAGR) of 33.2%. The growth in the forecast period can be attributed to advancements in computational biology, integration of multi-modal data, convergence of AI and life sciences, regulatory support and frameworks, ethical and fair AI principles. Major trends in the forecast period include integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.

Artificial Intelligence (AI) In Biopharmaceuticals Market Driver: Chronic Disease Prevalence Fueling Growth Of AI In Biopharmaceuticals Market

The growing prevalence of chronic diseases is expected to propel the growth of artificial intelligence (AI) in biopharmaceuticals market going forward. Chronic diseases are long-lasting conditions that generally progress slowly and may persist for years or even a lifetime. It arises from lifestyle factors, an aging population, genetic predispositions, and environmental factors. AI in biopharmaceuticals is increasingly used to manage chronic diseases because IT analyzes large volumes of diverse data sources, identifies patterns, and personalizes treatment approaches. For instance, in November 2023, according to the Department of Health and Human Services, a US-based government department in 2022, there was an 11 percent increase in newly reported chronic hepatitis B cases compared to 2021. Therefore, the growing prevalence of chronic diseases drives the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Global Artificial Intelligence (AI) In Biopharmaceuticals Market Major Players

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Global Artificial Intelligence (AI) In Biopharmaceuticals Market Trend: Advancements In AI-Powered Solutions For Drug Discovery And Precision Medicine

Major companies operating in artificial intelligence (AI) in biopharmaceuticals focus on developing innovative advancements such as target and lead identification suite AI-powered solutions to accelerate drug discovery and precision medicine to transform life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For instance, in May 2023, Google LLC, a US-based provider of cloud computing services, launched two new AI-powered tools called target and lead identification suites, designed to help researchers predict and understand the structure of proteins, which is a fundamental part of drug development. Additionally, this suite will help researchers ingest, store, analyze, and share mass amounts of genomic data, which is crucial for precision medicine. Also, these tools aim to streamline the drug discovery process, reduce costs, and bring new treatments to market faster. By providing efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and improve patient outcomes.

Artificial Intelligence (AI) In Biopharmaceuticals Market Merger And Acquisition: ZS Associates' Acquisition Of Trials.ai Inc. To Revolutionize Clinical Trial Design with AI

In February 2023, ZS Associates, a US-based management consulting and technology firm, acquired Trials.ai Inc. for an undisclosed amount. With this acquisition, Associates aims to enhance design processes within the pharmaceutical industry by leveraging artificial intelligence (AI) to optimize speed, improve participant experiences, and expedite the delivery of pharmaceutical therapies to the market. Trials.ai Inc. is a US-based company that focuses on revolutionizing clinical trials through artificial intelligence (AI) and machine learning (ML) technologies.

Regional Outlook For The Global Artificial Intelligence (AI) In Biopharmaceuticals Market

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI) In Biopharmaceuticals Industry?

The artificial intelligence (AI) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in biopharmaceuticals market statistics, including artificial intelligence (AI) in biopharmaceuticals industry global market size, regional shares, competitors with an artificial intelligence (AI) in biopharmaceuticals market share, detailed artificial intelligence (AI) in biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in biopharmaceuticals industry. This artificial intelligence (AI) in biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI) In Biopharmaceuticals Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $2.12 billion
Revenue Forecast In 2034 $6.67 billion
Growth Rate CAGR of 33.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes Subsegments: 1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics

    3. Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies

    4. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Artificial Intelligence (AI) In Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

    5.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Rate Analysis

    5.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM)

    6. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

    6.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hardware

    Software

    Services

    6.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cloud

    On-Premises

    6.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Machine Learning

    Natural Language Processing

    Deep Learning

    Other Technologies

    6.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Business Process And Supply Chain

    Drug Discovery

    Medical Imaging And Diagnostics

    Precision Medicine

    6.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Manufacturers

    Contract Research Organizations

    Academic And Government Research Institutes

    6.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    High-Performance Computing Systems

    AI-Enabled Laboratory Equipment

    Data Storage Solutions

    6.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Drug Discovery Platforms

    Clinical Trial Management Software

    Predictive Analytics Tools

    Natural Language Processing Solutions

    6.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Consulting Services

    Implementation And Integration Services

    Data Management And Analytics Services

    Training And Support Services

    7. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis

    7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market

    8.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Artificial Intelligence (AI) In Biopharmaceuticals Market

    9.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    9.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Artificial Intelligence (AI) In Biopharmaceuticals Market

    10.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market

    11.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    11.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market

    12.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market

    13.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market

    14.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    14.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

    15.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    15.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Artificial Intelligence (AI) In Biopharmaceuticals Market

    16.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market

    17.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Artificial Intelligence (AI) In Biopharmaceuticals Market

    18.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market

    19.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market

    20.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

    21.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    21.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market

    22.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Artificial Intelligence (AI) In Biopharmaceuticals Market

    23.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    23.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Artificial Intelligence (AI) In Biopharmaceuticals Market

    24.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    24.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market

    25.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    25.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Artificial Intelligence (AI) In Biopharmaceuticals Market

    26.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    26.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market

    27.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market

    28.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    28.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market

    29.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

    29.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles

    30.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape

    30.2. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles

    30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Google LLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Tencent Holdings Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies

    31.1. International Business Machines Corporation

    31.2. Exscientia Limited

    31.3. NVIDIA Corporation

    31.4. Amgen Inc.

    31.5. DeepMind Technologies Limited

    31.6. Schrödinger Inc.

    31.7. XtalPi Inc.

    31.8. ConcertAI Inc.

    31.9. Insilico Medicine Inc.

    31.10. Recursion Pharmaceuticals

    31.11. BenevolentAI

    31.12. BioXcel Therapeutics

    31.13. Atomwise Inc.

    31.14. BioAge Labs Inc.

    31.15. GNS Healthcare

    32. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

    34. Recent Developments In The Artificial Intelligence (AI) In Biopharmaceuticals Market

    35. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies

    35.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

    35.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

    35.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Apple Inc. Financial Performance
  • Table 80: Google LLC Financial Performance
  • Table 81: Microsoft Corporation Financial Performance
  • Table 82: Tencent Holdings Limited Financial Performance
  • Table 83: Amazon Web Services Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Apple Inc. Financial Performance
  • Figure 80: Google LLC Financial Performance
  • Figure 81: Microsoft Corporation Financial Performance
  • Figure 82: Tencent Holdings Limited Financial Performance
  • Figure 83: Amazon Web Services Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Artificial Intelligence (AI) In Biopharmaceuticals market?

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here

How will the Artificial Intelligence (AI) In Biopharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Artificial Intelligence (AI) In Biopharmaceuticals industry going forward?

The Artificial Intelligence (AI) In Biopharmaceuticals market major growth driver - Chronic Disease Prevalence Fueling Growth Of AI In Biopharmaceuticals Market. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here

What is the forecast market size or the forecast market value of the Artificial Intelligence (AI) In Biopharmaceuticals market?

The Artificial Intelligence (AI) In Biopharmaceuticals market size has grown strongly in recent years. The artificial intelligence (AI) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $1.59 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to advancements in computational power, biomedical data explosion, precision medicine paradigm, regulatory support and guidance. The artificial intelligence (AI) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $6.67 billion in 2029 at a compound annual growth rate (CAGR) of 33.2%. The growth in the forecast period can be attributed to advancements in computational biology, integration of multi-modal data, convergence of ai and life sciences, regulatory support and frameworks, ethical and fair ai principles. Major trends in the forecast period include integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here

How is the Artificial Intelligence (AI) In Biopharmaceuticals market segmented?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market,
request a sample here

Which region has the largest share of the Artificial Intelligence (AI) In Biopharmaceuticals market? What are the other regions covered in the report?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here.

Who are the major players in the Artificial Intelligence (AI) In Biopharmaceuticals market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here.

What are the key trends in the Artificial Intelligence (AI) In Biopharmaceuticals market?

Major trends in the Artificial Intelligence (AI) In Biopharmaceuticals market include Advancements In AI-Powered Solutions For Drug Discovery And Precision Medicine. For further insights on the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here.

What are the major opportunities in the Artificial Intelligence (AI) In Biopharmaceuticals market? What are the strategies for the Artificial Intelligence (AI) In Biopharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Artificial Intelligence (AI) In Biopharmaceuticals market, request a sample here.

How does the Artificial Intelligence (AI) In Biopharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Artificial Intelligence (AI) In Biopharmaceuticals's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Artificial Intelligence (AI) In Biopharmaceuticals industry?

For detailed insights on the mergers and acquisitions in the Artificial Intelligence (AI) In Biopharmaceuticals industry, request a sample here.

What are the key dynamics influencing the Artificial Intelligence (AI) In Biopharmaceuticals market growth? SWOT analysis of the Artificial Intelligence (AI) In Biopharmaceuticals market.

For detailed insights on the key dynamics influencing the Artificial Intelligence (AI) In Biopharmaceuticals market growth and SWOT analysis of the Artificial Intelligence (AI) In Biopharmaceuticals industry, request a sample here.